Overview
Neonatal herpes simplex virus (HSV) conjunctivitis is a rare but severe condition characterized by ocular infection in newborns, often part of a broader neonatal HSV infection that can affect the central nervous system, skin, eyes, and mucous membranes. 1Diagnosis
Clinical presentation includes conjunctival hyperemia, purulent discharge, and potential systemic symptoms.
Laboratory confirmation typically involves PCR testing of conjunctival swabs for HSV DNA.
Lumbar puncture may be necessary to assess for central nervous system involvement, with cerebrospinal fluid analysis for HSV DNA. 1Management
First-line treatment: Intravenous acyclovir is the mainstay, with dosing often adjusted based on gestational age and weight (e.g., 20 mg/kg every 8 hours).
Duration: Treatment duration varies but often extends for 14-21 days to cover potential latency periods.
Adjunctive measures: Supportive care including hydration, pain management, and monitoring for disseminated disease. 1Special Populations
Pregnancy: Maternal screening for HSV-2 during pregnancy is increasingly common but lacks universal recommendation due to insufficient evidence supporting its efficacy in preventing neonatal transmission. 1
Pediatrics: Neonatal HSV infections require prompt diagnosis and aggressive treatment to prevent severe complications and mortality.Key Recommendations
Maternal screening for HSV-2 during pregnancy is prevalent but not universally recommended due to lack of clear evidence supporting its effectiveness in preventing neonatal HSV infection. (Evidence: Expert opinion) 1
Neonatal HSV conjunctivitis should be suspected in neonates with ocular symptoms and requires prompt PCR testing of conjunctival swabs for HSV DNA confirmation. (Evidence: Moderate) 1
Intravenous acyclovir at 20 mg/kg every 8 hours is recommended for treatment, with a treatment course typically lasting 14-21 days. (Evidence: Moderate) 1References
1 Roberts S. Herpes simplex virus: incidence of neonatal herpes simplex virus, maternal screening, management during pregnancy, and HIV. Current opinion in obstetrics & gynecology 2009. link